Stock OBAGI MEDICAL PRODUCTS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Obagi Medical Products, Inc.

Equities

US67423R1086

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Obagi Medical Products, Inc.
2013 CONMED Corporation : Exclusive - Activist investor Voce pushes ConMed to sell RE
2013 Obagi Medical Products, Inc. : Valeant sweetens bid for Obagi Medical RE

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its Previously Announced Acquisition of Obagi Medical Products, Inc.
PR
Obagi Medical Products, Inc. : Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
PR
Obagi Medical Products, Inc. : and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash
BU
Obagi Medical Products, Inc. : Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
PR
Obagi Medical Products, Inc. : Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma
BU
Obagi Medical Products, Inc. : Merz Pharma Group Makes Superior Proposal to Acquire Obagi Medical Products
PR
Obagi Medical Products, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Obagi Medical Products, Inc.
PR
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. For $19.75 per Share in Cash
BU
Obagi Medical Products, Inc. : Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
PR
Obagi Medical Products, Inc. : Obagi Medical Products Reports Fourth Quarter and Year-End 2012 Financial Results
BU
Obagi Medical Products, Inc. : Obagi Medical Products to Report Fourth Quarter and Year End 2012 Financial Results and Host a Conference Call on March 14
BU
Obagi Medical Products, Inc. : Obagi Medical Products and Suneva Medical Partner to Offer ReGenica® Facial Rejuvenation Complex
BU
Obagi Medical Products, Inc. : Obagi Medical Confirms Receipt of Directors Nomination Notice from Voce Capital
BU
Obagi Medical Products, Inc. : Obagi Medical Products to Present at The Canaccord Genuity's Medical Technology and Diagnostics Forum Conference
BU
Obagi Medical Products, Inc. : Obagi Medical Products to Present at The 24th Annual Piper Jaffray Healthcare Conference
BU
Obagi Medical Products, Inc. : Obagi Medical Products Introduces Hydrate
BU
Obagi Medical Products, Inc. : Obagi Medical Products Reports Third Quarter 2012 Earnings; Company Provides Update to Key Initiatives
BU
Obagi Medical Products, Inc. : Obagi Medical Products to Report Third Quarter 2012 Financial Results and Host a Conference Call on November 1
BU
Obagi Medical Products, Inc. : Obagi Medical Products to Present at The Stifel Nicolaus Healthcare Conference
BU
Obagi Medical Products, Inc. : Obagi Medical Products Appoints Mark Taylor as Senior Vice President Corporate Development and Investor Relations
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Obagi Medical Products, Inc.
  5. Press Releases